Evidence map›Paper›PMID 21454350›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2011

Variability in urinary oxalate measurements between six international laboratories.

Naim M Maalouf, Beverley Adams Huet, Andreas Pasch, John C Lieske, John R Asplin, Roswitha Siener, Albrecht Hesse, Jean-Marc Nuoffer, Felix J Frey, John Knight and 3 more

Open access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. ALLN-177, oral enzyme therapy for hyperoxaluria.International urology and nephrology · 2019
    Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Naim M MaaloufDepartment of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
Beverley Adams Huet
Andreas Pasch
John C Lieske
John R Asplin
Roswitha Siener
Albrecht Hesse
Jean-Marc Nuoffer
Felix J Frey
John Knight
Ross P Holmes
Joseph E Zerwekh
Olivier Bonny
The University of Texas Southwestern Medical Center · USUniversity of Bern · CHUniversity of Bonn · DEWake Forest University · USLink Foundation · USMayo Clinic · USUniversity Hospital of Bern · CHUniversity of Lausanne · CH

Funding

MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AWARDK23RR021710 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI MAALOUF, NAIM M · 2005 to 2009
$582k
NCRR NIH HHS K23 RR021710NCRR NIH HHS K23-RR21710
6 · The paper itself

Abstract

backgroundHyperoxaluria is a major risk factor for kidney stone formation. Although urinary oxalate measurement is part of all basic stone risk assessment, there is no standardized method for this measurement.

methodsUrine samples from 24-h urine collection covering a broad range of oxalate concentrations were aliquoted and sent, in duplicates, to six blinded international laboratories for oxalate, sodium and creatinine measurement. In a second set of experiments, ten pairs of native urine and urine spiked with 10 mg/L of oxalate were sent for oxalate measurement. Three laboratories used a commercially available oxalate oxidase kit, two laboratories used a high-performance liquid chromatography (HPLC)-based method and one laboratory used both methods.

resultsIntra-laboratory reliability for oxalate measurement expressed as intraclass correlation coefficient (ICC) varied between 0.808 [95% confidence interval (CI): 0.427-0.948] and 0.998 (95% CI: 0.994-1.000), with lower values for HPLC-based methods. Acidification of urine samples prior to analysis led to significantly higher oxalate concentrations. ICC for inter-laboratory reliability varied between 0.745 (95% CI: 0.468-0.890) and 0.986 (95% CI: 0.967-0.995). Recovery of the 10 mg/L oxalate-spiked samples varied between 8.7 ± 2.3 and 10.7 ± 0.5 mg/L. Overall, HPLC-based methods showed more variability compared to the oxalate oxidase kit-based methods.

conclusionsSignificant variability was noted in the quantification of urinary oxalate concentration by different laboratories, which may partially explain the differences of hyperoxaluria prevalence reported in the literature. Our data stress the need for a standardization of the method of oxalate measurement.

Indexed as

Clinical Laboratory TechniquesHumansInternational CooperationLaboratoriesOxalatesReproducibility of ResultsOxalates

Identifiers

PMID21454350
PMCPMC3254161
OpenAlexW2078415156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.